4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001918845-26-000002
Options or other derivatives
- Chief Medical Officer acquired 105,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Doyle Mittie Chief Medical Officer | 2026-02-26 | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | D: show line 1 in the form |
Loading xslF345X05/form4-03022026_090303.xml…